76
Participants
Start Date
July 16, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Suvorexant
Suvorexant is described chemically as: \[(7R)-4-(5-chloro-2-benzoxazolyl) hexahydro-7-methyl-1H-1,4-diazepin-1-yl\]\[5-methyl-2-(2H-1,2,3-triazol2-yl)phenyl\]methanone. SUV's empirical formula is C23H23ClN6O2 and the molecular weight is 450.92. Each film coated tablet contains 10mg or 20mg of suvorexant.
Placebo
Film coated tablet to match the active drug.
RECRUITING
The University of Texas Health Science Center - Houston, Houston
RECRUITING
University of California - Los Angeles, Los Angeles
University of California, Los Angeles
OTHER
The University of Texas Health Science Center, Houston
OTHER
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
OTHER